Discussion in 'ME/CFS research news' started by Sly Saint, May 8, 2021.
Virios currently holds 20 patents that include composition of matter, a unique synergy patent and method of use patents for FM, IBS & CFS patents. as well as Functional Somatic Syndrome (recently renamed the Somatic Symptom Disorder (SSD). These additional chronic conditions represent a substantially larger market opportunity. The below listed SSD conditions are all chronic-pain related conditions. Based on blinded survey data, we believe that many of the SSD conditions will be responsive to treatment with IMC-1.
2. Irritable Bowel Syndrome
3. Chronic Pelvic Pain
4. Chronic Neck and Back Pain
5. Temporomandibular Joint Dysfunction (TMJ)
6. Frequent Headaches
This is the company begun from Skip Pridgen's protocols. He is on the board of Directors:
William L. Pridgen, M.D
William L. Pridgen, M.D. is our founder and has been a director since 2018. Dr. Pridgen is a board-certified surgeon practicing with Tuscaloosa Surgical Associates, P.C. in Tuscaloosa, Alabama. Dr. Pridgen obtained his B.S. in Biology from Rhodes College, attending the medical school and completing his surgical residency at the University of Tennessee College of Medicine. Dr. Pridgen is certified in general surgery and is a fellow of the American College of Surgeons. Dr. Pridgen has spent nearly 20 years searching for effective treatments in IBS, FM, and MECFS, and served as a physician and surgeon in the United States Navy for five years.
Are they (Skip Pridgen) the team doing the Phase 2B trial?
edit: added Skip Pridgen
How could Somatic Symptom Disorder possibly be successfully and/or ethically be treated using antivirals - given that the definition excludes any biological cause for symptoms?
Or, is it just a case of lets make some money from the sickies (doesn't matter if it's ethical or might work)?
(I am aware that most, if not all, people diagnosed with SSD probably have a biological reason for their symptoms, just not ones that a GP or his favourite psychiatrist can be bothered to look for. It just puzzles me how people who have decided that there can be no biomedical explanation, who then diagnose SSD, can then be happy to offer antivirals - to the same patients).
Is this another have cake, eat it, and then still have all the cake scenario?
Here is the phase 2b clinical Trial info from clinical trials.gov:
Virios Therapeutics’ Announces Dosing of First Patient in IMC-2 Long-COVID Treatment Trial
There doesn't seem to be anything in Clinical Trials for IMC-2 (there's one for IMC-002, but that seems to be a different treatment for a different disease and a different company). And yet the first patient is being dosed.
If anyone knows Lucinda Bateman, maybe they could ask her to ensure that the trial plan is lodged in the Clinical Trials register before the trial starts, for every trial that they have any involvement with? It's even more important when the trial is being done for a for-profit company.
The Bateman Horne Center must be turning a rather good profit by running these trials for speculative companies - which is fine, so long as they do a scrupulously great job. Pre-registration is surely a fundamental thing to do to avoid any suggestion of 'being able to be bought'.
The "Virus Hypothesis".
Separate names with a comma.